Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "IFF"

1804 News Found

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
News | June 12, 2026

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients


India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM
News | June 12, 2026

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion


Major UK study to evaluate newborn screening for spinal muscular atrophy
Healthcare | June 12, 2026

Major UK study to evaluate newborn screening for spinal muscular atrophy

SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme


MedGenome documentary highlights role of genomics in personalized cancer care
News | June 12, 2026

MedGenome documentary highlights role of genomics in personalized cancer care

The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer


Evonik unveils probiotic advance in fight against antibiotic resistance
R&D | June 11, 2026

Evonik unveils probiotic advance in fight against antibiotic resistance

Evonik researchers say they have achieved a significant breakthrough with Ecobiol


Glenmark launches Winlevi across key European markets
News | June 11, 2026

Glenmark launches Winlevi across key European markets

First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe


Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound
News | June 11, 2026

Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound

The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed


AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104
News | June 10, 2026

AmMax Bio licenses Lonza’s ADC tech to advance AML candidate AMB-104

The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities